Marksans Pharma has announced a final dividend of ₹0.90 per equity share for the financial year ended 31 March 2026, subject to approval at the upcoming Annual General Meeting (AGM). The AGM is scheduled for 27 August 2026 and will be conducted through video conferencing.
The company has set 20 August 2026 as the record date to determine the eligibility of members to receive the final dividend. If approved, the dividend will be paid on or after 10 September 2026, following the deduction of tax at source.
Marksans Pharma will send the AGM notice and the annual report for FY 2026 electronically to members whose email addresses are registered with the company or its registrar and transfer agent. These documents will also be available on the company’s website and the stock exchanges’ websites in due course.
The board meeting where these decisions were made commenced at 11:15 a.m. and concluded at 11:50 a.m. on 3 July 2026.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).